OBJECTIVES: To analyse the incidence, demographics and molecular epidemiology of invasive group A streptococcal (GAS) disease in New Zealand between 2002 and 2012. METHODS: Using laboratory-based surveillance data, invasive GAS isolates were identified from the Institute of Environmental Science and Research, New Zealand. Hospitalization and mortality data were obtained from the New Zealand Ministry of Health. Molecular typing was performed by sequence analysis of the emm gene. RESULTS: The incidence of invasive GAS infections increased from 3.9 per 100,000 population in 2002 to 7.9 per 100,000 population (P < 0.001) in 2012. The incidence was highest in the over 75-year age group, and in Pacific peoples. There was temporal variation in emm types associated with invasive GAS disease, with emm1 being the overall predominant emm type. The diversity of emm types varied significantly according to ethnicity. Overall, 59% of GAS isolates were theoretically covered by an experimental M-protein vaccine. CONCLUSIONS: Our study provides valuable data on the epidemiology of invasive GAS disease in New Zealand, and represents one of the few studies to assess such longitudinal data across an entire nation. The increase in invasive GAS disease is concerning, and reasons for this should be explored further.
OBJECTIVES: To analyse the incidence, demographics and molecular epidemiology of invasive group A streptococcal (GAS) disease in New Zealand between 2002 and 2012. METHODS: Using laboratory-based surveillance data, invasive GAS isolates were identified from the Institute of Environmental Science and Research, New Zealand. Hospitalization and mortality data were obtained from the New Zealand Ministry of Health. Molecular typing was performed by sequence analysis of the emm gene. RESULTS: The incidence of invasive GAS infections increased from 3.9 per 100,000 population in 2002 to 7.9 per 100,000 population (P < 0.001) in 2012. The incidence was highest in the over 75-year age group, and in Pacific peoples. There was temporal variation in emm types associated with invasive GAS disease, with emm1 being the overall predominant emm type. The diversity of emm types varied significantly according to ethnicity. Overall, 59% of GAS isolates were theoretically covered by an experimental M-protein vaccine. CONCLUSIONS: Our study provides valuable data on the epidemiology of invasive GAS disease in New Zealand, and represents one of the few studies to assess such longitudinal data across an entire nation. The increase in invasive GAS disease is concerning, and reasons for this should be explored further.
Authors: George E Nelson; Tracy Pondo; Karrie-Ann Toews; Monica M Farley; Mary Lou Lindegren; Ruth Lynfield; Deborah Aragon; Shelley M Zansky; James P Watt; Paul R Cieslak; Kathy Angeles; Lee H Harrison; Susan Petit; Bernard Beall; Chris A Van Beneden Journal: Clin Infect Dis Date: 2016-04-22 Impact factor: 9.079
Authors: Deborah A Williamson; Pierre R Smeesters; Andrew C Steer; John D Steemson; Adrian C H Ng; Thomas Proft; John D Fraser; Michael G Baker; Julie Morgan; Philip E Carter; Nicole J Moreland Journal: J Clin Microbiol Date: 2015-08-19 Impact factor: 5.948
Authors: Luchang Zhu; Randall J Olsen; Waleed Nasser; Stephen B Beres; Jaana Vuopio; Karl G Kristinsson; Magnus Gottfredsson; Adeline R Porter; Frank R DeLeo; James M Musser Journal: J Clin Invest Date: 2015-08-10 Impact factor: 14.808
Authors: Emma Sherwood; Stefania Vergnano; Isona Kakuchi; Michael G Bruce; Suman Chaurasia; Samara David; Angela Dramowski; Scarlett Georges; Rebecca Guy; Theresa Lamagni; Daniel Levy-Bruhl; Outi Lyytikäinen; Monika Naus; Jennifer Onukwube Okaro; Oddvar Oppegaard; Didrik F Vestrheim; Tammy Zulz; Andrew C Steer; Chris A Van Beneden; Anna C Seale Journal: Lancet Infect Dis Date: 2022-04-04 Impact factor: 71.421
Authors: Stephen B Beres; Priyanka Kachroo; Waleed Nasser; Randall J Olsen; Luchang Zhu; Anthony R Flores; Ivan de la Riva; Jesus Paez-Mayorga; Francisco E Jimenez; Concepcion Cantu; Jaana Vuopio; Jari Jalava; Karl G Kristinsson; Magnus Gottfredsson; Jukka Corander; Nahuel Fittipaldi; Maria Chiara Di Luca; Dezemona Petrelli; Luca A Vitali; Annessa Raiford; Leslie Jenkins; James M Musser Journal: mBio Date: 2016-05-31 Impact factor: 7.867
Authors: Francesca Latronico; Waleed Nasser; Kai Puhakainen; Jukka Ollgren; Hanne-Leena Hyyryläinen; Stephen B Beres; Outi Lyytikäinen; Jari Jalava; James M Musser; Jaana Vuopio Journal: J Infect Dis Date: 2016-10-05 Impact factor: 5.226
Authors: Stephen B Beres; Randall J Olsen; Matthew Ojeda Saavedra; Roisin Ure; Arlene Reynolds; Diane S J Lindsay; Andrew J Smith; James M Musser Journal: J Med Microbiol Date: 2017-11-03 Impact factor: 2.472